|
Quotes & Info
|
| SCLN > SEC Filings for SCLN > Form 8-K on 9-Nov-2012 | All Recent SEC Filings |
9-Nov-2012
Results of Operations and Financial Condition, Financial Statements
On November 9, 2012, SciClone Pharmaceuticals, Inc. issued a press release announcing final financial results for the third quarter ended September 30, 2012. The press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein in its entirety.
The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 to this Current Report on Form 8-K, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
(d) The following exhibits are filed herewith:
Exhibit 99.1 Press release dated November 9, 2012.
|
|